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Storage of platelets typically is at room temperature (RT) 
in large, gas permeable bags that allow some CO2 and 
O2 exchange. The bags are kept on an orbital shaker in a 
thermostable cabinet (22±2 ℃). These physical storage 
conditions were rationally selected following scientific 
breakthroughs in the previous century (1,2). RT storage was 
selected over storage at 4 ℃ based on the observation that 
cold-stored platelets are cleared significantly faster from 
circulation compared to RT (3). Although gold standard 
for decades now, RT storage is suboptimal because of the 
higher risk for bacterial bloom compared to 4 ℃ storage (4). 
Recent estimates suggest that still between 1:1,000 to 
1:2,500 platelet concentrates (PC) are contaminated with 
bacteria (5). Transfusion of a contaminated concentrate 
can cause sepsis and because patients often receive 
multiple units, their individual clinical risk for transfusion 
transmitted infection is a multiplicate of the mathematical 
risk for contamination of a single PC (6). It should be 
noted however that bacterial infection caused by platelet 
transfusion, and resulting in a serious adverse event is very 
rare in the EU with only 16 cases on 2.3 million platelet 
transfusions and one death in 2017 (EU DG Health and 
Food Safety 147152—10/01/2020). Nonetheless, to limit 
bacterial contamination PC shelf lives are mandatorily 
short and typically range from 4 to 7 days. This limitation 
continuously strains the inventory management of blood 
banks worldwide. Novel ways to extend platelet shelf life 
without risking sterility or quality, represent a major goal in 
transfusion medicine. 
PCs  can  be  admin i s te red  prophy lac t i ca l l y  to 
thrombocytopenic patients at risk for bleeding or 
therapeutically to actively bleeding patients. Platelet 
transfusion is prophylactic in the vast majority (>70%) 
of cases in the developed world (7). Because RT storage 
of platelets guarantees longer survival in circulation than 
4 ℃ storage, RT is optimal for prophylactic transfusion. 
However, extended circulation may not be relevant for the 
actively bleeding patient in need of immediate hemostasis. 
In this case, any efficacious platelet may serve, regardless 
the circulation time post transfusion. Which raises the 
question if 4 ℃ stored platelets would be a valid alternative 
for RT stored platelets in treating active bleeding. This can 
only be answered in a well-designed, properly powered, 
double blinded, randomized controlled clinical trial. But 
in the latest issue of Transfusion, Stolla et al. started to 
address this question (8). In their study, 4 ℃ stored platelets 
were compared to RT stored platelets for (I) recovery and 
survival after autologous transfusion in healthy volunteers 
and (II) for a selection of platelet in vitro parameters. 
In vivo platelet recovery was determined based on the 
fraction of 111In labeled platelets found in circulation two 
hours after transfusion of a pre-defined platelet number. 
Results of 4 ℃ stored platelets were expressed relative to 
fresh, autologous platelets. Platelet recovery gradually 
declined as a function of 4 ℃ storage time. Consequently, 
20 day 4 ℃ stored platelets had half the recovery of 5 day 
4 ℃ stored platelets. The results thus show that for every 
additional day of cold storage, the number of recovered 
platelets decreases. This finding suggests that even for the 
actively bleeding patient in need for immediate hemostasis 
platelet storage time at 4 ℃ may have to be curtailed. 
Especially because clinically significant bleeding often is 
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not a matter of minutes, but rather hours. This finding 
thus raises additional questions for clinical trial designers. 
These must take into account storage time as a significant 
variable or may choose to include it as part of the study 
question. Another consequence of this observation is that 
the “priming” for clearance is a continuing process during 
4 ℃ storage. This suggests that bringing platelets to low 
temperatures is not a single hit but instead follows a gradual 
course. Of note, the same experiment demonstrates that 
this “priming” for clearance takes place at RT as well 
because recovery of seven-day RT stored platelets is 30% 
lower compared to fresh RT platelets. Platelet “priming” 
thus is a substantial part of the platelet storage lesion at 
all temperatures. Stolla et al. now elegantly demonstrate 
that 4 ℃ storage indeed contributes to this phenomenon 
incessantly and significantly. 
Some biochemical “priming” factors behind the 4 ℃ 
storage lesion have been identified, primarily in mouse 
platelets (9-12). Interventions based on these findings 
have successfully prolonged platelet circulation time in 
murine models of transfusion (10,12), but have not (yet) 
successfully been translated to humans (13). More research 
is needed to fully understand the biochemistry of cold 
stored human platelets and the reasons for their poor 
recoveries. As a contribution to this quest, Stolla et al. have 
investigated a number of in vitro platelet parameters like 
platelet metabolism, P-selectin expression, integrin αIIbβ3 
activation, microparticle release and apoptosis markers. As 
expected (14,15), platelet metabolism significantly slows 
down at 4 ℃ following laws of thermodynamics. This may 
seem favorable to platelets because acidosis is detrimental 
and often a reason for discarding a regular RT stored 
PC (16,17). The slower metabolism does however not 
translate in a profoundly quiescent platelet. Integrin αIIbβ3 
for instance, is prematurely activated in resting cold stored 
platelets albeit slightly. This is a confirmation of previous 
research that indicated that intracellular Ca2+ fluxes underlie 
premature integrin activation in cold stored platelets (18). 
In addition, a gradual increase in microparticles was 
found in correspondence to Johnson et al. (15). Both 
high microparticle content and premature integrin αIIbβ3 
activation may indicate a destabilized platelet cytoskeleton 
(19,20). In line with this, platelet rounding and subsequent 
loss of swirl is often seen in 4 ℃ stored platelets (14). 
Spontaneous platelet granule release, a hallmark of 
platelet storage lesion, was delayed during cold storage in 
comparison to seven-day RT storage in this study. This was 
determined based on P-selectin (CD62P) expression and 
has been observed before (21). Shifting platelets to storage 
in additive solution may further slow down this particular 
effect of cold storage (18). 
Finally, platelet apoptosis markers were tested including 
mitochondrial membrane potential using the JC-1 probe, 
caspase 3,7 levels and phosphatidylserine expression. It is 
well known that platelets harbor apoptosis machinery (22) 
but it is yet to be established if this is relevant to 
transfusion. Increased caspase activity does not normally 
appear in RT stored platelets unless stored beyond 19 
days (23). Similar observations were made in the Stolla 
et al. study for 4 ℃ stored platelets. Phosphatidylserine 
expression increased almost linearly during 20-day storage 
at 4 ℃ and was significantly higher compared to seven day 
RT stored platelets at all timepoints. This suggests that 
platelets rapidly lose control over membrane asymmetry at 
4 ℃, in a continuous manner. We hypothesize that this is in 
line with the cytoskeletal and membrane mechanics changes 
that contribute to integrin activation and microparticle 
formation, but requires more research. It has been 
suggested that platelets expressing phosphatidylserine may 
be procoagulant and thus promote hemostasis (14,15,24). 
In fact, several groups have indeed demonstrated in vitro 
that thromboelastography, platelet aggregation and fibrin 
formation under flow are increased in cold stored platelets 
compared to RT storage (14,24,25). Whether this indeed 
translates to the clinic requires more research. 
The in vitro data included in the Stolla et al. paper are 
interesting, but limited to a selected set of parameters 
commonly used in blood banking research. To understand 
the basic biochemical changes induced by cold storage and 
the hemostatic consequences of this, researchers will have to 
dig deeper and perform assays investigating integral platelet 
function. In addition, in vitro findings should subsequently 
be tested in relevant models including rodent models (26), 
although these should also be interpreted with caution as 
regards to translatability (13). 
There is little scientific work assessing the clinical 
efficacy of cold stored platelets even though these platelets 
were transfused quite often historically (27). The choice of 
moving towards RT storage in those days was a logical one 
based on the genuine need for prolonged platelet circulation 
during prophylaxis (3). However, recent information 
published in the AABB 2017 congress proceedings suggests 
that at least in the setting of elective surgery with blood 
loss, cold stored platelets are efficacious (28). The increased 
interest of regulators, clinicians and blood institutions 
may eventually result in a dual inventory of both RT and 
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cold stored platelets, each supporting a specific group of 
patients based on indications and on acute need. Until 
then, substantially more randomized controlled clinical 
trials are needed in order to better understand the safety 
and efficacy of cold stored platelets. At the same time, basic 
laboratory research is still needed as well because Stolla 
et al. have elegantly demonstrated that long term cold 
storage of platelets significantly decreases platelet recovery 
and survival in healthy volunteers. We need to understand 
why this is in order to develop storage conditions or 
additives that can combine the best of both worlds: an 
efficacious storable platelet that circulates sufficiently long 
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